RT @drdavidliew: ORAL Surveillance In mod-severe RA pts >50yo, with CV RF & no hx malignancy, patient-years of ex
Tweet Content
ORAL Surveillance
In mod-severe RA pts >50yo, with CV RF & no hx malignancy, patient-years of exposure required for one event (vs TNFi):
MACE
tofa 5mg bid: 567
tofa 10mg bid: 319
malignancy
tofa 5mg bid: 276
tofa 10mg bid: 275
#ACR21 ABST0831 @RheumNow https://t.co/9vyXPTMFzj
Links
Safety and Efficacy of Tofacitinib vs TNF Inhibitors in RA Patients Aged 50 Yea…
https://acrabstracts.org/abstract/safety-and-efficacy-of-tofacitinib-vs-tnf-inh…
Show on Archive Page
On
Display in Search Results
On
PDQ
Off